[1] LIU L，REN ZG，SHEN Y，et al. Influence of hepatic artery occlusion on tumor growth and metastatic potential in a human orthotopic hepatoma nude mouse model:relevance of epithelial-mesenchymal transition[J]. Cancer Sci，2010，101（1）:120-128. （下转第305页）
[2] MARELLI L，SHUSANG V，BUSCOMBE JR，et al. Transarterial injection of（131）I-lipiodol，compared with chemoembolization，in the treatment of unresectable hepatocellular cancer[J]. J Nucl Med，2009，50（6）:871-877.
[3] PLEGUEZUELO M，MARELLI L，MISSERI M，et al. TACE versus TAE as therapy for hepatocellular carcinoma[J]. Expert Rev Anticancer Ther，2008，8（10）:1623-1641.
[4] OSUGA K，HORI S，HIRAISHI K. Bland embolization of hepatocellular carcinoma using superabsorbent polymermicrospheres[J]. Cardiovasc Intervent Radiol，2008，31（6）:1108-1116.
[5] MIRAGLIA R，PIETROSI G，MARUZZELLI L，et al. Efficacy of transcatheter embolization/chemoembolization （TAE/TACE）for the treatment of single hepatocellular carcinoma[J]. World J Gastroenterol，2007，13（21）:2952-2955.
[6] MARELLI L，STIGLIANO R，TRIANTOS C，et al. Transarterial therapy for hepatocellular carcinoma: which technique is more effective A systematic review of cohort and randomized studies[J]. Cardiovasc Intervent Radiol，2007，30（1）:6-25.
[7] OKITA K. Clinical aspects of hepatocellular carcinoma in Japan[J]. Intern Med，2006，45（5）:229-233.
[8] CILLO U，VITALE A，GRIGOLETTO F，et al. Prospective validation of the Barcelona clinic liver cancer staging system[J]. J Hepatol，2006，44（4）：723-732.
[9] 中国抗癌协会肝癌专业委员会. 原发性肝癌诊断标准[J]. 中华肝脏病杂志，2000，8（3）：135.
[10] 中华医学会中华放射学杂志编委会介入放射学组.肝癌介入治疗规范化条例（试行）[J].中华放射学杂志，2001，35（12）：887-891. |
